Current Edition

Aptar Pharma and RDD Online Partner to Present Reimagined RDD 2021 Virtual Conference, Live Events May 4-7, 2021

Aptar Pharma, leader in respiratory drug delivery solutions and RDD Online®, organizers of Respiratory Drug Delivery (RDD®) conferences, are pleased to announce their co-organization of Virtual RDD 2021 which will feature live discussions between May 4-7, 2021 and extended on-demand access to presentations from April 27- June 30, 2021. This virtual conference breaks traditional barriers between speakers, poster presenters and exhibitors to connect pulmonary and nasal drug delivery experts from around the world.

In response to the global pandemic, co-organizers RDD Online and Aptar Pharma have reimagined how delegates receive critical updates and interact with one another. As such, the renowned RDD Europe conference series continues this year as an innovative and exciting virtual event, which will bring the latest developments in respiratory drug delivery to a broader global audience on a timescale that respects everyones additional commitments during the pandemic.
“RDD conferences have been bringing the respiratory world together for years, but this year, RDD 2021 unites scientists and clinicians in industry, government and academia with renewed purpose,” said Richard Dalby, one of the RDD conference organizers.
Professor Gisli Jenkins, National Heart and Lung Institute, Imperial College London will deliver the keynote presentation addressing Mechanisms of Alveolar Injury and Fibrogenesis: Developing Stratified Approaches for Pulmonary Fibrosis Treatment. Themed Knowledge Spaces at RDD 2021 will deliver one-stop access to presentations from U.S. FDA, academic and industry experts, poster presentations from established and up and coming young scientists, as well as workshop presentations and exhibitions on the latest product developments and service innovations within the respiratory field. The RDD 2021 Knowledge Space themes are:
  • Pulmonary Progress: Respiratory Science Responds to SARS-CoV2 and Lung Diseases
  • Propelling Inhalation Forward: Tools to Facilitate Low GWP Propellant Transition
  • Towards Greener Connectivity: Balancing the Needs of Patients and Our Planet
  • Perfecting Inhaled Particles: Advanced Inhaled Formulation Science
  • Front and Center: The Nose: Evaluating Regional Nasal Deposition

From the Knowledge Spaces, delegates will have the opportunity to connect in real-time during Explore with Experts moderated discussions between 4:00–6:15PM CET on each day of live RDD 2021 events. RDD Messaging and Meeting scheduling will allow experts and delegates to interact both during and after the conference.
RDD 2021 will include the widely sought-after Workshop Presentations, which enable delegates to discover new solutions, explore opportunities and enter into dialogue directly with the workshop presenters. This year, Conversations with Workshop Presenters will take place on Thursday, May 6 at 5:15PM CET.
Throughout the conference, delegates will have access to the latest, innovative research, presented as on-demand 10-minute Poster Presentations. The peer-review team has selected the best poster abstracts which will be presented and discussed during the popular Posters on the Podium live discussion on Friday, May 7 at 4:00PM CET.

Aptar Pharma, Diamond Sponsor of RDD2021
As a global leader in delivering respiratory solutions for asthma and COPD, Aptar Pharma is proud to be both Co-Organizer and Diamond Sponsor at RDD 2021, and will host a workshop to review some of the challenges and possible solutions in transitioning to lower CO2 footprint pMDIs. The workshop, entitled “Next Generation Of Low CO2 Footprint Inhalers – How Can We Manage The Transition Together?” will be co-presented by Chris Baron, Director of Business Development in Asthma and COPD at Aptar Pharma and Segolene Sarrailh, Inhalation & New Products Laboratory Manager at Aptar Pharma.
Carolyn Penot, Director Operational Marketing, Aptar Pharma said, “While we can’t be together in person this year, there hasn’t been a more important time to assemble to discuss issues and opportunities in the respiratory space. We’re proud to have worked with RDD® Online to create what is sure to become the new standard in virtual conferences.”
One of the largest respiratory health conferences worldwide, RDD 2021 promises to once again bring the respiratory world together at a reimagined virtual conference that will include the best features of an in-person event augmented by a design that is only possible online.
To register as a delegate for RDD 2021, or to learn more about conference supporter, workshop and exhibition opportunities, go to
About RDD Online®
RDD Online manages the organization of Respiratory Drug Delivery conferences in the U.S., and partners with Aptar Pharma to run RDD® events in Europe and Asia. Other RDD Online services available at include the provision of scientific and technical publications, aerosol testing equipment, including mouth throat models and other hardware to facilitate realistic in vitro testing of aerosol products, web-based training, a company profile directory and recruiting services of interest to organizations active in pulmonary and nasal drug delivery. For more information, please visit
About Aptar Pharma
Aptar Pharma is part of AptarGroup, Inc., a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material solutions. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, personal care, home, food and beverage. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective packaging technologies for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has 13,000 dedicated employees in 20 countries. For more information, visit
Media Contacts:
Carolyn Penot
Aptar Pharma
+33 6 37 36 76 84
Richard Dalby
RDDOnline®, LLC
+1 (410) 706 3245